Toward the optimal dose metric in continuous renal replacement therapy

Int J Artif Organs. 2012 Jun;35(6):413-24. doi: 10.5301/ijao.5000041.

Abstract

Purpose: There is no consensus on the optimal method to measure delivered dialysis dose in patients with acute kidney injury (AKI). The use of direct dialysate-side quantification of dose in preference to the use of formal blood-based urea kinetic modeling and simplified blood urea nitrogen (BUN) methods has been recommended for dose assessment in critically-ill patients with AKI. We evaluate six different blood-side and dialysate-side methods for dose quantification.

Methods: We examined data from 52 critically-ill patients with AKI requiring dialysis. All patients were treated with pre-dilution CVVHDF and regional citrate anticoagulation. Delivered dose was calculated using blood-side and dialysis-side kinetics. Filter function was assessed during the entire course of therapy by calculating BUN to dialysis fluid urea nitrogen (FUN) ratios q/12 hours.

Results: Median daily treatment time was 1,413 min (1,260-1,440). The median observed effluent volume per treatment was 2,355 mL/h (2,060-2,863) (p<0.001). Urea mass removal rate was 13.0 ± 7.6 mg/min. Both EKR (r²=0.250; p<0.001) and KD (r²=0.409; p<0.001) showed a good correlation with actual solute removal. EKR and KD presented a decline in their values that was related to the decrease in filter function assessed by the FUN/BUN ratio.

Conclusions: Effluent rate (mL/kg/h) can only empirically provide an estimated of dose in CRRT. For clinical practice, we recommend that the delivered dose should be measured and expressed as KD. EKR also constitutes a good method for dose comparisons over time and across modalities.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acute Kidney Injury / blood
  • Acute Kidney Injury / physiopathology
  • Acute Kidney Injury / therapy*
  • Adult
  • Biomarkers / blood
  • Blood Urea Nitrogen
  • Creatinine / blood
  • Critical Illness
  • Dialysis Solutions / administration & dosage*
  • Dialysis Solutions / metabolism
  • Equipment Design
  • Female
  • Humans
  • Kinetics
  • Male
  • Membranes, Artificial
  • Middle Aged
  • Models, Biological
  • Renal Dialysis / instrumentation
  • Renal Dialysis / methods*
  • Treatment Outcome
  • United States
  • Urea / blood
  • Urination

Substances

  • Biomarkers
  • Dialysis Solutions
  • Membranes, Artificial
  • Urea
  • Creatinine